International Journal of Cancer Management

Published by: Kowsar

Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines

Mahdieh Shokrollahi Barough 1 , 3 , Hadi Hasanzadeh 2 , Mehdi Barati 1 , 3 , Fatemeh Pak 1 , Parviz Kokhaei 1 , 4 , 5 , * and Mostafa Rezaei-Tavirani 6
Authors Information
1 Cancer Research Center, Department of Immunology, Semnan University of Medical Sciences, Semnan, IR Iran
2 Department of Medical Physics, Cancer Research Center, Semnan University of Medical Sciences, Semnan, IR Iran
3 Student’s Research Committee, Semnan University of Medical Sciences, Semnan, IR Iran
4 Immunology Research Center, Iran University of Medical Sciences, Tehran, IR Iran
5 Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Solna and Karolinska Institute, Immune and Gene Therapy Laboratory, Karolinska University Hospital, Stockholm, Sweden
6 Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: December 28, 2015, 8 (6); e4193
  • Published Online: December 23, 2015
  • Article Type: Research Article
  • Received: October 1, 2015
  • Accepted: November 21, 2015
  • DOI: 10.17795/ijcp-4193

To Cite: Shokrollahi Barough M, Hasanzadeh H, Barati M, Pak F, Kokhaei P, et al. Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines, Int J Cancer Manag. 2015 ; 8(6):e4193. doi: 10.17795/ijcp-4193.

Abstract
Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Wang WL, Porter W, Burghardt R, Safe SH. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis. 1997; 18(5): 925-33[PubMed]
  • 2. Shafie SM, Grantham FH. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst. 1981; 67(1): 51-6[PubMed]
  • 3. Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, et al. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer (Auckl). 2010; 4: 35-41[PubMed]
  • 4. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 1990; 50(3): 717-21[PubMed]
  • 5. Chavez KJ, Garimella SV, Lipkowitz S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis. 2010; 32(1-2): 35-48[DOI][PubMed]
  • 6. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005; 5(10): 773-85[DOI][PubMed]
  • 7. Rivera E, Gomez H. Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res. 2010; 12 Suppl 2[DOI][PubMed]
  • 8. Breast cancer and endocrine therapy 2014. 2014;
  • 9. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10(6): 515-27[DOI][PubMed]
  • 10. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer. 2005; 5(3): 231-7[DOI][PubMed]
  • 11. Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011; 30: 87[DOI][PubMed]
  • 12. Signore M, Ricci-Vitiani L, De Maria R. Targeting apoptosis pathways in cancer stem cells. Cancer Lett. 2013; 332(2): 374-82[DOI][PubMed]
  • 13. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5): 646-74[DOI][PubMed]
  • 14. Trump BF, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol. 1997; 25(1): 82-8[PubMed]
  • 15. Amaravadi RK, Thompson CB. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res. 2007; 13(24): 7271-9[DOI][PubMed]
  • 16. Shan X, Wang D, Chen J, Xiao X, Jiang Y, Wang Y, et al. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer. J Comput Assist Tomogr. 2013; 37(1): 22-8[DOI][PubMed]
  • 17. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140(6): 883-99[DOI][PubMed]
  • 18. Gentile M, Latonen L, Laiho M. Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses. Nucleic Acids Res. 2003; 31(16): 4779-90[PubMed]
  • 19. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med. 2006; 12(9): 440-50[DOI][PubMed]
  • 20. Artiukhov VG, Zemchenkova OV, Basharina OV, Riazantsev SV, Pashkov MV. [Apoptosis and necrosis of lymphocytes induced by UV-radiation in the presence of autological plasma]. Tsitologiia. 2014; 56(1): 77-83[PubMed]
  • 21. Golstein P, Ojcius DM, Young JD. Cell death mechanisms and the immune system. Immunol Rev. 1991; 121: 29-65[PubMed]
  • 22. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell. 2010; 140(6): 798-804[DOI][PubMed]
  • 23. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem. 1997; 272(41): 25783-6[PubMed]
  • 24. Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol Immunother. 1997; 44(5): 282-90[PubMed]
  • 25. Chatterjee M, Wu S. Involvement of Fas receptor and not tumor necrosis factor-alpha receptor in ultraviolet-induced activation of acid sphingomyelinase. Mol Carcinog. 2001; 30(1): 47-55[PubMed]
  • 26. Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA, et al. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol. 1998; 140(1): 171-82[PubMed]
  • 27. Wu S, Loke HN, Rehemtulla A. Ultraviolet radiation-induced apoptosis is mediated by Daxx. Neoplasia. 2002; 4(6): 486-92[DOI][PubMed]
  • 28. Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol. 2003; 170(1): 114-22[PubMed]
  • 29. O'Connell J, Bennett MW, O'Sullivan GC, O'Callaghan J, Collins JK, Shanahan F. Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege. Clin Diagn Lab Immunol. 1999; 6(4): 457-63[PubMed]
  • 30. Rahman M, Davis SR, Pumphrey JG, Bao J, Nau MM, Meltzer PS, et al. TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat. 2009; 113(2): 217-30[DOI][PubMed]
  • 31. Tu CC, Kumar VB, Day CH, Kuo WW, Yeh SP, Chen RJ, et al. Estrogen receptor alpha (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins. J Mol Endocrinol. 2013; 51(1): 203-12[DOI][PubMed]
  • 32. Pollheimer MJ, Kornprat P, Lindtner RA, Harbaum L, Schlemmer A, Rehak P, et al. Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol. 2010; 41(12): 1749-57[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments